Crit Care Med. 2010 Apr;38(4):1197-205.

The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.

Lin PC1, Chang CH, Hsu PI, Tseng PL, Huang YB.

Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Chen YF1, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

Intern Med. 2010;49(18):1965-70. Epub 2010 Sep 15.

Measles-related hospitalizations and complications in Japan, 2007-2008.

Yasunaga H1, Shi Y, Takeuchi M, Horiguchi H, Hashimoto H, Matsuda S, Ohe K.

Pediatr Blood Cancer. 2013 Oct;60(10):E122-4. doi: 10.1002/pbc.24575. Epub 2013 Apr 29.Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak.

Roy Moulik N1, Kumar A, Jain A, Jain P.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1259-1269.

Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies.

Medlock S1, Eslami S, Askari M, Taherzadeh Z, Opondo D, de Rooij SE, Abu-Hanna A.

Curr Med Res Opin. 2014 Mar;30(3):367-80.

Comparison of the efficacy and safety of low molecular weight heparins for venous thromboembolism prophylaxis in medically ill patients.

Dooley C1, Kaur R, Sobieraj DM.